Rapid In Vitro Screening of Drug–Metal Ion Interactions

REFERENCES

• Aymard J. P., Aymard B., Netter P., Bannwarth B., Trechot P., Streiff F. Haematological adverse effects of histamine H2-receptor antagonists. Med. Toxicol. Adverse Drug Exp. 1988; 3(6)430–448
   PubMedGoogle Scholar
• Bachmann K. A., Sullivan T. J., Jauregui L., Reese J., Miller K., Levine L. Drug interactions of H2-receptor antagonists. Scand. J. Gastroenterol. Suppl. 1994; 206: 14–19
   PubMedGoogle Scholar
• Beard J., Borel M., Peterson F. J. Changes in iron status during weight loss with very-low-energy diets. Am. J. Clin. Nutr. 1997; 66(1)104–110
   PubMed Web of Science ®Google Scholar
• Beard J. L., Borel M. J., Derr J. Impaired thermoregulation and thyroid function in iron-deficiency anemia. Am. J. Clin. Nutr. 1990; 52(5)813–819
   PubMed Web of Science ®Google Scholar
• Beers M. H. The Merck Manual of Geriatrics. Merck & Co., Inc., New Jersey 2000, http://www.merck.com/mrkshared/mmg/home.jsp.
   Google Scholar
• Beers M. H. Clinical pharmacology. In The Merck Manual of Diagnosis and Therapy. Merck & Co. Inc., White house Station, New Jersey 2005, http://www.merck.com/mrk.shared/mmanual/section22/chapter299/299a.jsp.
   Google Scholar
• Campbell N. R., Kara M., Hasinoff B. B., Haddara W. M., McKay D. W. Norfloxacin interaction with antacids and minerals. Br. J. Clin. Pharmacol. 1992; 33(1)115–116
   PubMed Web of Science ®Google Scholar
• Campbell N. R. C., Hasinoff B. B., Stalts H., Rao B., Wong N. C. W. Ferrous sulfate reduces levothyroxine efficacy in patients with hypothyroidism. Ann. Intern. Med. 1992; 117(12)1010–1013
   PubMed Web of Science ®Google Scholar
• Carr R. E., Henkind P. Ocular manifestations of ethambutol. Arch. Ophthalmol. 1962; 67: 566–571
   PubMed Web of Science ®Google Scholar
• Chau L. Drug-associated nutritional problems in older persons. Rev. Clin. Gerontol. 2004; 13: 183–193
   Google Scholar
• Citron K. M., Thomas G. O. Ocular toxicity from ethambutol (editorial). Thorax 1986; 41: 737–739
   PubMed Web of Science ®Google Scholar
• Cole A., May P. M., Williams D. R. Metal binding by pharmaceuticals. Part 1. Copper(II) and zinc(II) interactions following ethambutol administration. Inflamm. Res. 1981; 11(3)296–305
   Google Scholar
• Esipenko B. E., Marsakova N. V. The effect of copper on the metabolism of iodine, carbohydrates and proteins in rats. Fiziol. Zh. 1990; 36(2)35–43, http://www.health2us.com/zn_cu.htm.
   PubMedGoogle Scholar
• U.S. Food and Drug Administration. The FDA Drug Approval Process. 2002, http://idid.essortment.com/fdadrugapprova_rrgy.htm
   Google Scholar
• Galla J. H. Metabolic alkalosis. J. Am. Soc. Nephrol. 2000; 11: 369–375
   PubMed Web of Science ®Google Scholar
• Geraldes C. F. G. C., Gil V. M. S., Teixeira M. H. S. F., Teixeira F. NMR studies of cimetidine and ranitidine in solution: acid-base equilibria and effects of antacids. Congr. AMPERE Magn. Reson. Relat. Phenom. Proc. 1984; 22: 392–393, CA.102:137713.
   Google Scholar
• Gringauz A. Introduction to Medicinal Chemistry—How Drugs Act and Why. Wiley-VCH, New York 1997
   Google Scholar
• Grossman L. I., Brickman B. M. Some observations on the pH of saliva. J. Dent. Res. 1937; 16(5)409–416
   Google Scholar
• Hoffken G., Borner K., Glatzel P. D., Koeppe P., Lode H. Reduced enteral absorption of ciprofloxacin in the presence of antacids. Eur. J. Clin. Microbiol. 1985; 4(3)345
   PubMedGoogle Scholar
• Kralik A., Kirchgessner M., Eder K. Z. Concentrations of thyroid hormones in serum and activity of hepatic 5’ monodeiodinase in copper-deficient rats. Ernahrungswiss 1996; 35(3)288–291, http://www.health2us.com/zn_cu.htm.
   PubMedGoogle Scholar
• Leedman P. J., Stein A. R., Chin W. W., Rogers J. T. Thyroid hormone modulates the interaction between iron regulatory proteins and the ferritin mRNA iron-responsive element. J. Biol. Chem. 1996; 271(20)12017–12023
   PubMed Web of Science ®Google Scholar
• Leibold J. E. The ocular toxicity of ethambutol and its relation to dose. Ann. N. Y. Acad. Sci. 1966; 135: 904–909
   PubMed Web of Science ®Google Scholar
• Lomaestro B. M., Bailie G. R. Effect of multiple staggered doses of calcium on the bioavailability of ciprofloxacin. Ann. Pharmacother. 1993; 27(11)1325–1328
   PubMed Web of Science ®Google Scholar
• Mizuno S., Demura Y., Ameshima S., Okamura S., Miyamori I., Ishizaki T. Alkalosis stimulates endothelial nitric oxide synthase in cultured human pulmonary arterial endothelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2002; 283: L113–L119
   Web of Science ®Google Scholar
• National Institutes of Health. Resource information–understanding clinical trials. 2002, http://www.clinicaltrials.gov/
   Google Scholar
• Oliver J. W. Interrelationships between athyroetic and copper-deficient states in rats. Am. J. Vet. Res. 1975; 36(11)1649–1653, http://www.health2us.com/zn_cu.htm.
   PubMed Web of Science ®Google Scholar
• Shakir K. M., Chute J. P., Aprill B. S., Lazarus A. A. Ferrous sulfate-induced increase in requirement for levothyroxine in a patient with primary hypothyroidism. South Med. J. 1997; 90(6)637–639
   PubMed Web of Science ®Google Scholar
• Shargel L. Pharmacy Review. John Wiley & Sons, New York 1990
   Google Scholar
• Shvartsburg A. A., Wilkes J. G. Fragmentation chemistry of DMSO complexes of metal dications. J. Phys. Chem. A. 2002; 106(18)4543–4551
   Web of Science ®Google Scholar
• Solecki T. J., Aviv A., Bogden J. D. Effect of a chelating drug on balance and tissue distribution of four essential metals. Toxicology 1984; 31(3–4)207–216
   PubMed Web of Science ®Google Scholar
• Sturniolo G. C., Montino M. C., Rossetto L., Martin A., D'Inca R., D'Odorico A., Naccarato R. Inhibition of gastric acid secretion reduces zinc absorption in man. J. Am. Coll. Nutr. 1991; 10(4)372–375
   PubMed Web of Science ®Google Scholar
• van de Waterbeemd H, Lennernäs H., Matuschek P. A., Hendriks W., McGhie T., Reynolds G. Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability. John Wiley & Sons, New York 2003
   Google Scholar
• van Hecken A M., Tjandramaga T. B., Mullie A., Verbesselt R., de Schepper P. J. Ranitidine: single dose pharmacokinetics and absolute bioavailability in man. Br. J. Clin. Pharmacol. 1982; 14: 195–200
   PubMed Web of Science ®Google Scholar
• Weismann K. Chelating drugs and zinc. Dan. Med. Bull. 1986; 33(4)208–211
   PubMed Web of Science ®Google Scholar
• Yang Y. F., Ohashi H., Walfish P. G. In vivo expression of rat liver c-erbA beta thyroid hormone receptor in yeast (Saccharomyces cerevisiae). Biochem. Biophys. Res. Commun. 1990; 171(1)138–142
   PubMed Web of Science ®Google Scholar